W81XWH-22-OPORP-CRA: DoD Orthotics and Prosthetics Outcomes, Clinical Research Award
Closed
This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2022.
Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 5 awards worth $5.0 million in total. Applications closed on June 1, 2022.
From the official notice on Grants.gov, last changed March 22, 2022. Checked November 7, 2026.
- Total funding$5.0 million
- Expected awards5
- Cost sharingNot required
- Funding typeCooperative Agreement, Grant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HT9425-23-OPORP-CRA | April 27, 2023 | Closed July 12, 2023 | Closed |
| W81XWH-21-OPORP-CRA | April 1, 2021 | Closed July 29, 2021 | Closed |
Key dates
| Posted | March 22, 2022 |
|---|---|
| Deadline | June 1, 2022 |
| Archived by Grants.gov | July 1, 2022 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the program's money (59% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The FY22 OPORP CRA is intended to support clinical research that evaluates orthoses and/or prostheses using patient-centric outcomes relevant to Service Members and military beneficiaries, Veterans, and other individuals with limb loss and/or limb impairment. Research supported by this mechanism is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical or policy decisions. The FY22 OPORP is also interested in multidisciplinary projects that address strategies to mitigate secondary injuries. Studies proposing or evaluating rehabilitation strategies must indicate how the rehabilitation may improve the orthotic or prosthetic device outcome when compared to standard of care. The FY22 OPORP CRA offers funding for two Funding Levels (refer to Section II.D.5, Funding Restrictions). Only one Funding Level category may be chosen per application, and the choice of application category is at the discretion of the applicant. The following are generalized descriptions of the scope of research appropriate for each Funding Level: The FY22 OPORP CRA is intended to support clinical research that evaluates orthoses and/or prostheses using patient-centric outcomes relevant to Service Members and military beneficiaries, Veterans, and other individuals with limb loss and/or limb impairment. Research supported by this mechanism is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical or policy decisions. The FY22 OPORP is also interested in multidisciplinary projects that address strategies to mitigate secondary injuries. Studies proposing or evaluating rehabilitation strategies must indicate how the rehabilitation may improve the orthotic or prosthetic device outcome when compared to standard of care. The FY22 OPORP CRA offers funding for two Funding Levels (refer to Section II.D.5, Funding Restrictions). Only one Funding Level category may be chosen per application, and the choice of application category is at the discretion of the applicant. The following are generalized descriptions of the scope of research appropriate for each Funding Level: • Funding Level 1 supports pilot and early-stage research studies that are explanatory and involve limited human exposure (e.g., small sample size), with the potential to make significant advancements toward clinical translation. Preliminary data are encouraged but not required for this Funding Level.
Who has won Military Medical Research and Development grants before
From fiscal 2021 to 2025, Military Medical Research and Development (12.420) awarded $6.9 billion across 5,470 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Maryland | 81 | $546 million |
| The Univeristy of Texas M.D. Anderson Cancer Center | Texas | 139 | $166 million |
| The Johns Hopkins University | Maryland | 157 | $153 million |
| The Regents of the University of California, San Francisco | California | 113 | $147 million |
| Duke University | North Carolina | 86 | $123 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is W81XWH-22-OPORP-CRA still open?
No. It closed on June 1, 2022. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).
Who can apply for DoD Orthotics and Prosthetics Outcomes, Clinical Research Award?
Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.
What is the deadline for DoD Orthotics and Prosthetics Outcomes, Clinical Research Award?
Closed June 1, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $5.0 million in total across about 5 awards.
Who has won Military Medical Research and Development grants before?
The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.